<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cardiovasc. Med.</journal-id>
<journal-title>Frontiers in Cardiovascular Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cardiovasc. Med.</abbrev-journal-title>
<issn pub-type="epub">2297-055X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcvm.2025.1481749</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cardiovascular Medicine</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Advances in diagnosis, management, and long-term outcomes of pediatric vasovagal syncope: a comprehensive review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Wenjing</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib>
<contrib contrib-type="author"><name><surname>Bian</surname><given-names>Xueyan</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Lv</surname><given-names>Jianli</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/2635670/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><institution>Department of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong Provincial Clinical Research Center for Children&#x2019;s Health and Disease Office</institution>, <addr-line>Jinan, Shandong</addr-line>, <country>China</country></aff>
<aff id="aff2"><label><sup>2</sup></label><institution>Department of Pediatrics, Lixia District People&#x2019;s Hospital</institution>, <addr-line>Jinan, Shandong</addr-line>, <country>China</country></aff>
<aff id="aff3"><label><sup>3</sup></label><institution>Department of Pediatric Cardiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong Provincial Clinical Research Center for Children&#x2019;s Health and Disease Office</institution>, <addr-line>Jinan, Shandong</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> Robert Sheldon, University of Calgary, Canada</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Marija Vavlukis, Ss. Cyril and Methodius University in Skopje, North Macedonia</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Jianli Lv <email>drjllv@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub"><day>25</day><month>04</month><year>2025</year></pub-date>
<pub-date pub-type="collection"><year>2025</year></pub-date>
<volume>12</volume><elocation-id>1481749</elocation-id>
<history>
<date date-type="received"><day>16</day><month>08</month><year>2024</year></date>
<date date-type="accepted"><day>10</day><month>04</month><year>2025</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2025 Zhu, Bian and Lv.</copyright-statement>
<copyright-year>2025</copyright-year><copyright-holder>Zhu, Bian and Lv</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Vasovagal syncope (VVS) is the most common cause of transient loss of consciousness in children and adolescents, accounting for 60&#x0025;&#x2013;80&#x0025; of syncope cases. This review synthesizes current evidence on pediatric VVS, focusing on advances in diagnosis, management, and long-term outcomes. Through a comprehensive literature search of studies published between 2001 and 2024, we analyzed epidemiological patterns, pathophysiological mechanisms, diagnostic approaches, management strategies, and prognostic factors. Recent diagnostic advances include implantable loop recorders and smartphone applications, which have improved diagnostic accuracy. Management has evolved toward individualized approaches, emphasizing non-pharmacological interventions (hydration, salt supplementation, physical counterpressure maneuvers) as first-line treatment, with medications such as midodrine and fludrocortisone showing variable efficacy in refractory cases. Long-term studies indicate that while most children experience improvement over time, 33&#x0025;&#x2013;50&#x0025; have recurrent episodes within three years, with factors such as lower mean arterial pressure, higher urine specific gravity, younger age, family history of syncope, and lower body mass index associated with increased recurrence risk. Though generally benign, VVS can significantly impact quality of life and carries substantial psychosocial consequences. Future research should focus on developing predictive models for recurrence risk and exploring personalized treatment approaches to improve outcomes.</p>
</abstract>
<kwd-group>
<kwd>vasovagal syncope</kwd>
<kwd>pediatric</kwd>
<kwd>diagnosis</kwd>
<kwd>management</kwd>
<kwd>outcomes</kwd>
</kwd-group><counts>
<fig-count count="1"/>
<table-count count="0"/><equation-count count="0"/><ref-count count="68"/><page-count count="7"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Pediatric Cardiology</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body><sec id="s1" sec-type="intro"><label>1</label><title>Introduction</title>
<p>Vasovagal syncope (VVS) represents the predominant etiology of transient loss of consciousness in pediatric and adolescent populations, accounting for approximately 60&#x0025;&#x2013;80&#x0025; of syncope cases (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B3">3</xref>). Characterized by an abrupt, temporary loss of consciousness resulting from global cerebral hypoperfusion, VVS manifests as a consequence of an exaggerated autonomic response to various triggers, precipitating bradycardia and/or peripheral vasodilation (<xref ref-type="bibr" rid="B4">4</xref>).</p>
<p>Despite its prevalence, the diagnosis and management of pediatric VVS present significant challenges. The clinical presentation varies considerably, and the differential diagnosis encompasses a spectrum of conditions from benign neurocardiogenic syndromes to potentially life-threatening cardiac conditions (<xref ref-type="bibr" rid="B5">5</xref>). Recent advances in diagnostic modalities and management strategies have improved outcomes, yet significant knowledge gaps persist regarding long-term prognosis and optimal treatment approaches for refractory cases (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>This review aims to synthesize current evidence on pediatric VVS, highlighting recent advances in diagnosis and management while identifying knowledge gaps that should guide future research.</p>
</sec>
<sec id="s2" sec-type="methods"><label>2</label><title>Methods</title>
<p>We conducted a comprehensive literature search following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Electronic databases including PubMed/MEDLINE, EMBASE, and the Cochrane Library were searched for articles published between January 2001 and March 2024. The search strategy employed keywords and Medical Subject Headings (MeSH) terms including &#x201C;vasovagal syncope,&#x201D; &#x201C;neurocardiogenic syncope,&#x201D; &#x201C;pediatric,&#x201D; &#x201C;children,&#x201D; &#x201C;adolescents,&#x201D; &#x201C;diagnosis,&#x201D; &#x201C;management,&#x201D; and &#x201C;outcomes&#x201D; in various combinations.</p>
<p>Inclusion criteria were: (1) studies focusing on VVS in pediatric populations (age &#x2264;18 years); (2) publications in English; (3) studies addressing aspects of diagnosis, management, or outcomes. We prioritized original research, systematic reviews, meta-analyses, and evidence-based clinical guidelines. After initial screening titles and abstracts, relevant articles underwent full-text review by two independent reviewers, with disagreements resolved through consensus discussion.</p>
<p>Due to the heterogeneity of study designs and outcome measures, we employed a narrative synthesis approach, organizing evidence according to key themes including epidemiology, pathophysiology, diagnosis, management, and long-term outcomes, with emphasis on pediatric-specific considerations and recent advances.</p>
</sec>
<sec id="s3" sec-type="results"><label>3</label><title>Results</title>
<sec id="s3a"><label>3.1</label><title>Literature search results</title>
<p>The literature search process and results are summarized in <xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>. Initial database searches yielded 1,245 potentially relevant citations. After removing duplicates (<italic>n</italic>&#x2009;&#x003D;&#x2009;215), 1,030 articles were screened based on titles and abstracts. Of these, 728 were excluded for not meeting inclusion criteria. The remaining 302 articles underwent full-text review, resulting in 175 articles being excluded for various reasons (not specific to pediatric population, not focused on VVS, or being case reports with limited generalizability). Ultimately, 127 articles were included in this comprehensive review.</p>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p>Flow diagram of literature search and selection process.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-12-1481749-g001.tif"/>
</fig>
</sec>
<sec id="s3b"><label>3.2</label><title>Epidemiological patterns of pediatric VVS</title>
<p>Our analysis of epidemiological studies revealed significant patterns in the prevalence and distribution of VVS in children and adolescents. VVS accounts for 60&#x0025;&#x2013;80&#x0025; of syncope cases in pediatric populations (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B3">3</xref>), with syncope representing 1&#x0025;&#x2013;3&#x0025; of emergency department visits and having an overall incidence of 0.1&#x0025;&#x2013;0.5&#x0025; in the pediatric population (<xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>Age-specific patterns show that the incidence of VVS increases dramatically during adolescence, peaking between ages 15&#x2013;19 years (<xref ref-type="bibr" rid="B2">2</xref>). Population-based studies demonstrate a notable gender disparity, with a cumulative incidence of 41&#x0025; for females and 28&#x0025; for males (<xref ref-type="bibr" rid="B9">9</xref>). Female sex is consistently identified as a significant risk factor, with girls being 1.5&#x2013;2 times more likely to experience VVS than boys (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>).</p>
<p>Additional predisposing factors include family history of syncope, low body mass index, anxiety disorders and orthostatic intolerance (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Environmental triggers such as dehydration, prolonged standing, and exposure to hot environments are commonly identified (<xref ref-type="bibr" rid="B4">4</xref>), while a sedentary lifestyle and poor physical conditioning may increase susceptibility (<xref ref-type="bibr" rid="B14">14</xref>).</p>
<p>The recurrence rate of VVS in children and adolescents is substantial. Studies report that 33&#x0025;&#x2013;50&#x0025; of patients experience at least one recurrent episode within three years of the initial event (<xref ref-type="bibr" rid="B15">15</xref>). However, the frequency and severity of episodes tend to decrease over time, with many patients experiencing improvement by early adulthood (<xref ref-type="bibr" rid="B16">16</xref>).</p>
<p>Despite its generally benign nature, VVS carries a significant economic burden, estimated at several hundred million dollars annually in the United States (<xref ref-type="bibr" rid="B17">17</xref>), reflecting costs associated with emergency department visits, hospitalizations, and diagnostic evaluations.</p>
</sec>
<sec id="s3c"><label>3.3</label><title>Pathophysiological mechanisms underlying pediatric VVS</title>
<p>The pathophysiology of VVS involves complex interactions between cardiovascular, neurological, and neuroendocrine systems. The fundamental process involves a sudden, inappropriate decrease in systemic blood pressure and/or heart rate, leading to transient global cerebral hypoperfusion (<xref ref-type="bibr" rid="B18">18</xref>).</p>
<p>The classic model centers on the Bezold-Jarisch reflex, a cardio-inhibitory response triggered by mechanoreceptors (C-fibers) in the left ventricle (<xref ref-type="bibr" rid="B19">19</xref>). In susceptible individuals, various stimuli such as prolonged standing or emotional stress lead to excessive venous pooling and reduced venous return. This results in vigorous contraction of an underfilled left ventricle, activating mechanoreceptors and initiating the reflex (<xref ref-type="bibr" rid="B18">18</xref>).</p>
<p>The activated reflex causes paradoxical bradycardia and vasodilation through increased parasympathetic activity and withdrawal of sympathetic tone (<xref ref-type="bibr" rid="B20">20</xref>). This response is mediated by the nucleus tractus solitarius in the brainstem, which receives afferent signals from mechanoreceptors and modulates efferent autonomic outflow (<xref ref-type="bibr" rid="B21">21</xref>).</p>
<p>Recent research has highlighted the role of impaired baroreflex sensitivity in VVS. Studies have demonstrated that children with recurrent VVS exhibit reduced baroreflex sensitivity compared to healthy controls, suggesting dysfunction in blood pressure homeostasis (<xref ref-type="bibr" rid="B22">22</xref>).</p>
<p>Neuroendocrine factors also contribute to VVS pathophysiology. Elevated levels of epinephrine have been observed during syncopal episodes, potentially exacerbating vasodilation (<xref ref-type="bibr" rid="B23">23</xref>). Alterations in serotonergic neurotransmission have been implicated in modulating central autonomic responses (<xref ref-type="bibr" rid="B24">24</xref>).</p>
<p>Genetic factors may predispose certain individuals to VVS, with familial clustering observed and potential genetic loci identified (<xref ref-type="bibr" rid="B13">13</xref>). Age-related differences in autonomic function, particularly during puberty, may explain the increased prevalence in adolescents. Puberty is associated with significant changes in cardiovascular autonomic regulation, including alterations in baroreflex sensitivity and sympathovagal balance (<xref ref-type="bibr" rid="B25">25</xref>).</p>
</sec>
<sec id="s3d"><label>3.4</label><title>Advances in diagnostic approaches for pediatric VVS</title>
<p>The diagnosis of VVS in children requires a comprehensive approach, combining careful history-taking, physical examination, and selective use of diagnostic tests. The primary goal is to differentiate VVS from other potentially life-threatening causes of syncope (<xref ref-type="bibr" rid="B26">26</xref>).</p>
<p>A detailed clinical history remains the cornerstone of VVS diagnosis. Key elements include identifying precipitating factors such as prolonged standing or emotional stress (<xref ref-type="bibr" rid="B4">4</xref>); recognizing prodromal symptoms like lightheadedness, nausea, and visual changes (<xref ref-type="bibr" rid="B27">27</xref>); characterizing the event, including duration and rapid recovery (<xref ref-type="bibr" rid="B28">28</xref>); and assessing post-syncopal such as fatigue and nausea (<xref ref-type="bibr" rid="B29">29</xref>).</p>
<p>Physical examination should include comprehensive cardiovascular assessment (heart rate, blood pressure, orthostatic measurements) and neurological examination to exclude other etiologies (<xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>While diagnosis is often based on clinical presentation, several diagnostic tests may be employed. A 12-lead ECG is recommended for all children presenting with syncope to rule out cardiac causes such as long QT syndrome or Brugada syndrome (<xref ref-type="bibr" rid="B2">2</xref>). Echocardiography may be indicated when structural heart disease is suspected based on history, examination, or ECG findings (<xref ref-type="bibr" rid="B30">30</xref>).</p>
<p>The Head-Up Tilt Table Test (HUTT) is considered the gold standard for diagnosing VVS, with a sensitivity of 60&#x0025;&#x2013;70&#x0025; and specificity of 90&#x0025;&#x2013;95&#x0025; in pediatric populations (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>). The test involves passive standing on a tilt table at a 60&#x2013;70 degree angle for up to 45&#x2005;min, with continuous monitoring of heart rate and blood pressure. A positive test is defined as the reproduction of syncope or pre-syncope associated with hypotension and/or bradycardia (<xref ref-type="bibr" rid="B33">33</xref>).</p>
<p>Recent technological advances have expanded the diagnostic arsenal. Implantable loop recorders (ILRs) allow for long-term cardiac monitoring in cases of recurrent, unexplained syncope. A study by Placidi et al. demonstrated the effectiveness of miniaturized ILRs in pediatric patients, enabling correlation of symptoms with cardiac rhythm (<xref ref-type="bibr" rid="B34">34</xref>). Exercise stress testing may be useful in cases of exertion-related syncope (<xref ref-type="bibr" rid="B35">35</xref>).</p>
<p>Smartphone-based ECG applications represent another significant advancement, providing non-invasive, cost-effective means of arrhythmia detection (<xref ref-type="bibr" rid="B36">36</xref>). These technologies facilitate ambulatory monitoring and may improve diagnostic yield in cases where conventional monitoring is inconclusive.</p>
<p>Diagnostic challenges in pediatric VVS include variability in presentation across different age groups (<xref ref-type="bibr" rid="B37">37</xref>), difficulty obtaining clear history from younger children (<xref ref-type="bibr" rid="B38">38</xref>), and symptom overlap with other conditions, particularly anxiety disorders (<xref ref-type="bibr" rid="B39">39</xref>). Careful consideration of differential diagnoses, including cardiac syncope, neurological causes such as seizures, orthostatic hypotension, and psychogenic pseudosyncope, is essential (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>).</p>
</sec>
<sec id="s3e"><label>3.5</label><title>Evolution of management strategies for pediatric VVS</title>
<p>Management of VVS in pediatric patients has evolved toward a multifaceted, individualized approach based on clinical presentation, episode frequency, and impact on quality of life (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B42">42</xref>).</p>
<p>Non-pharmacological interventions form the cornerstone of VVS management. Comprehensive patient and family education is essential, focusing on trigger identification and avoidance (<xref ref-type="bibr" rid="B43">43</xref>). Optimizing hydration (&#x003E;2&#x2005;L/day) and salt intake (&#x003E;6&#x2005;g/day) has shown effectiveness, particularly in patients with orthostatic intolerance (<xref ref-type="bibr" rid="B44">44</xref>). Physical counterpressure maneuvers, involving isometric muscle contractions to augment venous return during prodromal symptoms, have demonstrated efficacy in reducing syncope recurrence (<xref ref-type="bibr" rid="B45">45</xref>).</p>
<p>Structured exercise programs focusing on aerobic conditioning and lower limb strength training have shown promise. A randomized controlled trial reported that yoga as an adjunctive therapy significantly reduced syncopal and presyncopal events and improved quality of life compared to standard therapy alone (<xref ref-type="bibr" rid="B46">46</xref>). Orthostatic training (tilt training), involving progressively prolonged periods of upright posture, has also demonstrated effectiveness. Clinical experience suggests that these interventions pose no harm and may improve outcomes and reduce the frequency of episodes (<xref ref-type="bibr" rid="B47">47</xref>).</p>
<p>Pharmacological interventions are typically reserved for patients with frequent, severe episodes or those refractory to non-pharmacological measures. Fludrocortisone, a mineralocorticoid promoting sodium and water retention, has been studied in children with VVS. However, the multicenter Prevention of Syncope Trial (POST) 2 did not meet its primary objective of demonstrating significant reduction in syncope recurrence compared to placebo (<xref ref-type="bibr" rid="B48">48</xref>).</p>
<p>Midodrine, an &#x03B1;1-adrenergic agonist increasing peripheral vascular resistance, has shown more promise. A randomized controlled study in children with VVS demonstrated that the addition of midodrine hydrochloride to conventional therapy significantly reduced syncope recurrence rates compared to conventional therapy alone, with a significantly lower recurrence rate during follow-up periods of at least 6 months (<xref ref-type="bibr" rid="B49">49</xref>). Beta-blockers, while commonly prescribed, have demonstrated limited efficacy. A randomized controlled trial comparing metoprolol to conventional treatment in children and adolescents found no significant difference in syncope recurrence (<xref ref-type="bibr" rid="B50">50</xref>).</p>
<p>Selective serotonin reuptake inhibitors (SSRIs) may modulate central autonomic responses (<xref ref-type="bibr" rid="B51">51</xref>), but pediatric data are limited. Invasive interventions, including cardiac pacing with rate-drop response algorithms and catheter ablation of ganglionated plexus (<xref ref-type="bibr" rid="B52">52</xref>&#x2013;<xref ref-type="bibr" rid="B54">54</xref>), are rarely indicated in pediatric VVS and reserved for severe, refractory cases (<xref ref-type="bibr" rid="B55">55</xref>).</p>
<p>A stepwise approach to management is recommended, beginning with education and lifestyle modifications, progressing to structured exercise programs, and considering pharmacological therapy for frequent or severe cases.</p>
<p>Regular follow-up is essential to assess treatment efficacy and adjust management strategies. Objective measures, such as the Calgary Syncope Symptom Score or quality of life assessments, can be utilized to quantify clinical improvement (<xref ref-type="bibr" rid="B56">56</xref>).</p>
<p>Special considerations in pediatric VVS management include addressing the psychological burden through cognitive-behavioral therapy or other psychological interventions (<xref ref-type="bibr" rid="B57">57</xref>), and individualized risk stratification for young athletes (<xref ref-type="bibr" rid="B58">58</xref>).</p>
<p>Several novel approaches are under investigation for refractory VVS, such as ivabradine (a selective If channel inhibitor) (<xref ref-type="bibr" rid="B59">59</xref>). Given the benign nature of VVS, cost-effectiveness should be a consideration in management decisions, with a conservative approach being most cost-effective for initial management (<xref ref-type="bibr" rid="B60">60</xref>).</p>
</sec>
<sec id="s3f"><label>3.6</label><title>Long-term outcomes and prognostic factors in pediatric VVS</title>
<p>The prognosis of VVS in children is generally favorable, with most patients experiencing improvement or resolution of symptoms over time. However, natural history and long-term outcomes vary significantly among individuals.</p>
<p>The natural course of pediatric VVS tends toward spontaneous improvement. A study of 29 pediatric patients with neurocardiogenic syncope found that clinical events were greatly reduced in both treated and untreated groups during follow-up, with recurrences becoming unlikely after 24 months (<xref ref-type="bibr" rid="B61">61</xref>). This improvement is thought to be related to physiological maturation of the autonomic nervous system and adaptation to orthostatic stress.</p>
<p>Despite the overall favorable prognosis, recurrence rates remain substantial. In a study of 352 children with VVS followed for a median of 22 months, factors associated with an increased risk of recurrence included lower mean arterial pressure in the supine position, higher urine specific gravity, younger age, family history of syncope, and lower body mass index (<xref ref-type="bibr" rid="B62">62</xref>). The study developed a prognostic nomogram model incorporating these factors, which showed good predictive ability for 1-year, 2-year, and 3-year recurrence rates.</p>
<p>While not life-threatening, VVS can significantly impact quality of life. A cross-sectional study using the PedsQL&#x2122; 4.0 Generic Core Scales found that children with recurrent VVS had lower scores in physical, emotional, and social functioning compared to healthy controls (<xref ref-type="bibr" rid="B63">63</xref>). However, with appropriate management and patient education, most children can achieve good symptom control and maintain normal activities (<xref ref-type="bibr" rid="B64">64</xref>).</p>
<p>There is no evidence suggesting that childhood VVS is associated with increased cardiovascular morbidity or mortality in adulthood. A large population-based cohort study with a median follow-up of 17 years found no increased risk of major adverse cardiovascular events in individuals with VVS history compared to the general population (<xref ref-type="bibr" rid="B65">65</xref>).</p>
<p>The psychological impact of VVS in children and adolescents should not be underestimated. A prospective case-control study found significantly higher rates of psychopathology in VVS patients compared to controls, with 21.3&#x0025; meeting criteria for major depressive disorder (vs. 2&#x0025; of controls) and 19.1&#x0025; diagnosed with social anxiety disorder, generalized anxiety disorder, or conversion disorder (<xref ref-type="bibr" rid="B57">57</xref>). Early intervention and psychological support may mitigate these long-term psychosocial effects.</p>
<p>Several factors predict long-term outcomes in pediatric VVS. A higher number of syncopal episodes prior to diagnosis predicts a more protracted course (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B66">66</xref>), while early improvement with conservative measures suggests favorable long-term outcomes (<xref ref-type="bibr" rid="B45">45</xref>).</p>
<p>For young athletes with VVS, prognosis is generally good with appropriate management. Many are able to return to competitive activities after proper diagnosis and treatment (<xref ref-type="bibr" rid="B67">67</xref>). Children with a predominantly cardioinhibitory response on tilt testing may have higher risk of recurrent syncope and injury (<xref ref-type="bibr" rid="B68">68</xref>), but long-term studies have not demonstrated increased risk of sudden cardiac death in this subgroup (<xref ref-type="bibr" rid="B65">65</xref>).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion"><label>4</label><title>Discussion</title>
<p>This comprehensive review highlights significant advances in understanding and managing pediatric VVS, while also identifying persistent challenges and knowledge gaps. Our findings underscore the multifaceted nature of VVS in children and adolescents, requiring individualized diagnostic and management approaches.</p>
<p>The epidemiological data presented confirm that VVS represents a significant health burden in pediatric populations, with a notable peak during adolescence and higher prevalence in females. This gender disparity warrants further investigation into potential hormonal and physiological factors that may contribute to increased susceptibility in girls.</p>
<p>Recent diagnostic advances, including implantable loop recorders and smartphone-based ECG applications, have expanded the toolkit for clinicians evaluating syncope in children. However, these technologies should complement rather than replace thorough clinical assessment. The traditional approach of detailed history-taking and physical examination remains the cornerstone of diagnosis, with technological adjuncts providing valuable confirmatory evidence.</p>
<p>Our review of management strategies reveals a paradigm shift toward non-pharmacological interventions as first-line therapy. The demonstrated efficacy of hydration, salt supplementation, physical counterpressure maneuvers, and structured exercise programs supports a conservative initial approach. The variable efficacy of pharmacological options suggests the need for improved patient selection criteria to identify those most likely to benefit from medication.</p>
<p>The long-term outcome data present a generally reassuring picture, with most children experiencing improvement over time. However, the substantial recurrence rate (33&#x0025;&#x2013;50&#x0025; within three years) and identified risk factors for recurrence highlight the need for prognostic tools to guide monitoring and management intensity. The development of validated prediction models, such as the nomogram described by Sun et al. (<xref ref-type="bibr" rid="B62">62</xref>), represents a promising step toward personalized risk stratification.</p>
<p>Several important limitations in current evidence merit consideration. First, many studies have relatively short follow-up periods, limiting understanding of very long-term outcomes extending into adulthood. Second, heterogeneity in outcome measures across studies complicates direct comparison of intervention efficacy. Third, most studies have not addressed the impact of comorbidities, particularly psychological conditions, on VVS presentation and management.</p>
<p>Future research should focus on several key areas. Genetic and molecular studies may identify specific markers for VVS susceptibility, enabling targeted therapies. Longitudinal studies with extended follow-up are needed to elucidate the natural history into adulthood. Randomized controlled trials of emerging therapies, particularly in refractory cases, would address significant treatment gaps. Finally, standardization of outcome measures across studies would facilitate meta-analysis and strengthen evidence-based recommendations.</p>
<p>From a clinical perspective, our findings support a stepwise, individualized approach to VVS management, beginning with education and lifestyle modifications before considering pharmacological interventions. The significant psychosocial impact of VVS underscores the importance of addressing both physical and psychological aspects of the condition. Multidisciplinary collaboration among cardiologists, neurologists, psychologists, and primary care providers would optimize comprehensive care.</p>
</sec>
<sec id="s5" sec-type="conclusions"><label>5</label><title>Conclusion</title>
<p>This review synthesizes current evidence on pediatric VVS, highlighting advances in diagnosis, management, and understanding of long-term outcomes. While technological innovations have improved diagnostic capabilities, and evidence increasingly supports non-pharmacological interventions as first-line therapy, significant challenges remain in predicting individual outcomes and managing refractory cases.</p>
<p>VVS in children represents a complex clinical entity requiring individualized assessment and management. Although generally benign with favorable long-term prognosis, its impact on quality of life and potential psychological consequences necessitate comprehensive care approaches.</p>
<p>Future research should focus on developing robust prediction models for recurrence risk, evaluating emerging therapeutic options, and establishing standardized outcome measures to strengthen the evidence base. By bridging the gap between scientific advances and clinical practice, we can continue to improve outcomes for the many children and adolescents affected by VVS.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="author-contributions"><title>Author contributions</title>
<p>WZ: Conceptualization, Investigation, Writing &#x2013; original draft. XB: Data curation, Investigation, Writing &#x2013; review &#x0026; editing. JL: Conceptualization, Supervision, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec id="s7" sec-type="funding-information"><title>Funding</title>
<p>The author(s) declare that no financial support was received for the research and/or publication of this article.</p>
</sec>
<ack><title>Acknowledgments</title>
<p>The authors thank the Shandong Provincial Hospital Affiliated to Shandong First Medical University and the Shandong Provincial Clinical Research Center for Children&#x0027;s Health and Disease office for their support. We appreciate the assistance of colleagues in the Department of Pediatric Cardiology and the library staff for accessing relevant literature.</p>
</ack>
<sec id="s8" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Massin</surname><given-names>MM</given-names></name><name><surname>Bourguignont</surname><given-names>A</given-names></name><name><surname>Coremans</surname><given-names>C</given-names></name><name><surname>Comte</surname><given-names>L</given-names></name><name><surname>Lepage</surname><given-names>P</given-names></name><name><surname>Gerard</surname><given-names>P</given-names></name></person-group>. <article-title>Syncope in pediatric patients presenting to an emergency department</article-title>. <source>J Pediatr</source>. (<year>2004</year>) <volume>145</volume>:<fpage>223</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2004.01.048</pub-id><pub-id pub-id-type="pmid">15289772</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>JWJ</given-names></name><name><surname>Cho</surname><given-names>CS</given-names></name></person-group>. <article-title>Pediatric syncope: cases from the emergency department</article-title>. <source>Emerg Med Clin North Am</source>. (<year>2010</year>) <volume>28</volume>:<fpage>501</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.emc.2010.03.009</pub-id><pub-id pub-id-type="pmid">20709241</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kanjwal</surname><given-names>K</given-names></name><name><surname>Calkins</surname><given-names>H</given-names></name></person-group>. <article-title>Syncope in children and adolescents</article-title>. <source>Cardiol Clin</source>. (<year>2015</year>) <volume>33</volume>:<fpage>397</fpage>&#x2013;<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccl.2015.04.008</pub-id><pub-id pub-id-type="pmid">26115826</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>JM</given-names></name><name><surname>van Dijk</surname><given-names>JG</given-names></name><name><surname>Balaji</surname><given-names>S</given-names></name><name><surname>Sutton</surname><given-names>R</given-names></name></person-group>. <article-title>A framework to simplify paediatric syncope diagnosis</article-title>. <source>Eur J Pediatr</source>. (<year>2023</year>) <volume>182</volume>:<fpage>4771</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1007/s00431-023-05114-w</pub-id><pub-id pub-id-type="pmid">37470792</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>WK</given-names></name><name><surname>Sheldon</surname><given-names>RS</given-names></name><name><surname>Benditt</surname><given-names>DG</given-names></name><name><surname>Cohen</surname><given-names>MI</given-names></name><name><surname>Forman</surname><given-names>DE</given-names></name><name><surname>Goldberger</surname><given-names>ZD</given-names></name><etal/></person-group> <article-title>2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart rhythm society</article-title>. <source>Circulation</source>. (<year>2017</year>) <volume>136</volume>:<fpage>e60</fpage>&#x2013;<lpage>e122</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0000000000000499</pub-id><pub-id pub-id-type="pmid">28280231</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McIntyre-Patton</surname><given-names>L</given-names></name><name><surname>Wanderski</surname><given-names>S</given-names></name><name><surname>Graef</surname><given-names>D</given-names></name><name><surname>Woessner</surname><given-names>L</given-names></name><name><surname>Baker</surname><given-names>R</given-names></name></person-group>. <article-title>Randomized trial evaluating the effectiveness of a leg crossing and muscle tensing technique on decreasing vasovagal symptoms among pediatric and young adult patients undergoing peripheral IV catheter insertion</article-title>. <source>J Pediatr Nurs</source>. (<year>2018</year>) <volume>38</volume>:<fpage>53</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.pedn.2017.09.012</pub-id><pub-id pub-id-type="pmid">29167081</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Behnoush</surname><given-names>AH</given-names></name><name><surname>Yazdani</surname><given-names>K</given-names></name><name><surname>Khalaji</surname><given-names>A</given-names></name><name><surname>Tavolinejad</surname><given-names>H</given-names></name><name><surname>Aminorroaya</surname><given-names>A</given-names></name><name><surname>Jalali</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Pharmacologic prevention of recurrent vasovagal syncope: a systematic review and network meta-analysis of randomized controlled trials</article-title>. <source>Heart Rhythm</source>. (<year>2023</year>) <volume>20</volume>:<fpage>448</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2022.12.010</pub-id><pub-id pub-id-type="pmid">36509319</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fant</surname><given-names>C</given-names></name><name><surname>Cohen</surname><given-names>A</given-names></name></person-group>. <article-title>Syncope in pediatric patients: a practical approach to differential diagnosis and management in the emergency department</article-title>. <source>Pediatr Emerg Med Pract</source>. (<year>2017</year>) <volume>14</volume>:<fpage>1</fpage>&#x2013;<lpage>28</lpage>.<pub-id pub-id-type="pmid">28362251</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ganzeboom</surname><given-names>KS</given-names></name><name><surname>Mairuhu</surname><given-names>G</given-names></name><name><surname>Reitsma</surname><given-names>JB</given-names></name><name><surname>Linzer</surname><given-names>M</given-names></name><name><surname>Wieling</surname><given-names>W</given-names></name><name><surname>van Dijk</surname><given-names>N</given-names></name></person-group>. <article-title>Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35&#x2013;60 years</article-title>. <source>J Cardiovasc Electrophysiol</source>. (<year>2006</year>) <volume>17</volume>:<fpage>1172</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1111/j.1540-8167.2006.00595.x</pub-id><pub-id pub-id-type="pmid">17074006</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ganzeboom</surname><given-names>KS</given-names></name><name><surname>Colman</surname><given-names>N</given-names></name><name><surname>Reitsma</surname><given-names>JB</given-names></name><name><surname>Shen</surname><given-names>WK</given-names></name><name><surname>Wieling</surname><given-names>W</given-names></name></person-group>. <article-title>Prevalence and triggers of syncope in medical students</article-title>. <source>Am J Cardiol</source>. (<year>2003</year>) <volume>91</volume>:<fpage>1006</fpage>&#x2013;<lpage>8</lpage>, <comment>A1008</comment>. <pub-id pub-id-type="doi">10.1016/s0002-9149(03)00127-9</pub-id><pub-id pub-id-type="pmid">12686351</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>JB</given-names></name><name><surname>Czosek</surname><given-names>RJ</given-names></name><name><surname>Cnota</surname><given-names>J</given-names></name><name><surname>Meganathan</surname><given-names>K</given-names></name><name><surname>Knilans</surname><given-names>TK</given-names></name><name><surname>Heaton</surname><given-names>PC</given-names></name></person-group>. <article-title>Pediatric syncope: national hospital ambulatory medical care survey results</article-title>. <source>J Emerg Med</source>. (<year>2012</year>) <volume>43</volume>:<fpage>575</fpage>&#x2013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.jemermed.2012.01.020</pub-id><pub-id pub-id-type="pmid">22406025</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ojha</surname><given-names>A</given-names></name><name><surname>Chelimsky</surname><given-names>TC</given-names></name><name><surname>Chelimsky</surname><given-names>G</given-names></name></person-group>. <article-title>Comorbidities in pediatric patients with postural orthostatic tachycardia syndrome</article-title>. <source>J Pediatr</source>. (<year>2011</year>) <volume>158</volume>:<fpage>20</fpage>&#x2013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2010.07.005</pub-id><pub-id pub-id-type="pmid">20723911</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matveeva</surname><given-names>N</given-names></name><name><surname>Titov</surname><given-names>B</given-names></name><name><surname>Bazyleva</surname><given-names>E</given-names></name><name><surname>Pevzner</surname><given-names>A</given-names></name><name><surname>Favorova</surname><given-names>O</given-names></name></person-group>. <article-title>Towards understanding the genetic nature of vasovagal syncope</article-title>. <source>Int J Mol Sci</source>. (<year>2021</year>) <volume>22</volume>:<fpage>10316</fpage>. <pub-id pub-id-type="doi">10.3390/ijms221910316</pub-id><pub-id pub-id-type="pmid">34638656</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koene</surname><given-names>RJ</given-names></name><name><surname>Adkisson</surname><given-names>WO</given-names></name><name><surname>Benditt</surname><given-names>DG</given-names></name></person-group>. <article-title>Syncope and the risk of sudden cardiac death: evaluation, management, and prevention</article-title>. <source>J Arrhythm</source>. (<year>2017</year>) <volume>33</volume>:<fpage>533</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.joa.2017.07.005</pub-id><pub-id pub-id-type="pmid">29255498</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kouakam</surname><given-names>C</given-names></name><name><surname>Vaksmann</surname><given-names>G</given-names></name><name><surname>Pachy</surname><given-names>E</given-names></name><name><surname>Lacroix</surname><given-names>D</given-names></name><name><surname>Rey</surname><given-names>C</given-names></name><name><surname>Kacet</surname><given-names>S</given-names></name></person-group>. <article-title>Long-term follow-up of children and adolescents with syncope; predictor of syncope recurrence</article-title>. <source>Eur Heart J</source>. (<year>2001</year>) <volume>22</volume>:<fpage>1618</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1053/euhj.2000.2577</pub-id><pub-id pub-id-type="pmid">11492992</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheldon</surname><given-names>RS</given-names></name><name><surname>Sheldon</surname><given-names>AG</given-names></name><name><surname>Connolly</surname><given-names>SJ</given-names></name><name><surname>Morillo</surname><given-names>CA</given-names></name><name><surname>Klingenheben</surname><given-names>T</given-names></name><name><surname>Krahn</surname><given-names>AD</given-names></name><etal/></person-group> <article-title>Age of first faint in patients with vasovagal syncope</article-title>. <source>J Cardiovasc Electrophysiol</source>. (<year>2006</year>) <volume>17</volume>:<fpage>49</fpage>&#x2013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1111/j.1540-8167.2005.00267.x</pub-id><pub-id pub-id-type="pmid">16426400</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>BC</given-names></name><name><surname>Emond</surname><given-names>JA</given-names></name><name><surname>Camargo</surname><given-names>CA</given-names><suffix>Jr</suffix></name></person-group>. <article-title>Direct medical costs of syncope-related hospitalizations in the United States</article-title>. <source>Am J Cardiol</source>. (<year>2005</year>) <volume>95</volume>:<fpage>668</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjcard.2004.11.013</pub-id><pub-id pub-id-type="pmid">15721118</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martone</surname><given-names>AM</given-names></name><name><surname>Parrini</surname><given-names>I</given-names></name><name><surname>Ciciarello</surname><given-names>F</given-names></name><name><surname>Galluzzo</surname><given-names>V</given-names></name><name><surname>Cacciatore</surname><given-names>S</given-names></name><name><surname>Massaro</surname><given-names>C</given-names></name><etal/></person-group> <article-title>Recent advances and future directions in syncope management: a comprehensive narrative review</article-title>. <source>J Clin Med</source>. (<year>2024</year>) <volume>13</volume>:<fpage>727</fpage>. <pub-id pub-id-type="doi">10.3390/jcm13030727</pub-id><pub-id pub-id-type="pmid">38337421</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>HX</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name></person-group>. <article-title>Advance in the understanding of vasovagal syncope in children and adolescents</article-title>. <source>World J Pediatr</source>. (<year>2021</year>) <volume>17</volume>:<fpage>58</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1007/s12519-020-00367-z</pub-id><pub-id pub-id-type="pmid">32405708</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Dijk</surname><given-names>JG</given-names></name><name><surname>Wieling</surname><given-names>W</given-names></name></person-group>. <article-title>Pathophysiological basis of syncope and neurological conditions that mimic syncope</article-title>. <source>Prog Cardiovasc Dis</source>. (<year>2013</year>) <volume>55</volume>:<fpage>345</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.pcad.2012.10.016</pub-id><pub-id pub-id-type="pmid">23472770</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iwase</surname><given-names>S</given-names></name><name><surname>Nishimura</surname><given-names>N</given-names></name><name><surname>Mano</surname><given-names>T</given-names></name></person-group>. <article-title>Role of sympathetic nerve activity in the process of fainting</article-title>. <source>Front Physiol</source>. (<year>2014</year>) <volume>5</volume>:<fpage>343</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2014.00343</pub-id><pub-id pub-id-type="pmid">25309444</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alnoor</surname><given-names>MS</given-names></name><name><surname>Varner</surname><given-names>HK</given-names></name><name><surname>Butler</surname><given-names>IJ</given-names></name><name><surname>Lankford</surname><given-names>JE</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Numan</surname><given-names>MT</given-names></name></person-group>. <article-title>Arterial baroreceptor physiology: differences between normal subjects and pediatric patients with postural tachycardia and neurocardiogenic syncope</article-title>. <source>Pediatr Cardiol</source>. (<year>2022</year>) <volume>43</volume>:<fpage>1011</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s00246-022-02815-1</pub-id><pub-id pub-id-type="pmid">35089394</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>JM</given-names></name><name><surname>Medow</surname><given-names>MS</given-names></name><name><surname>Sutton</surname><given-names>R</given-names></name><name><surname>Visintainer</surname><given-names>P</given-names></name><name><surname>Jardine</surname><given-names>DL</given-names></name><name><surname>Wieling</surname><given-names>W</given-names></name></person-group>. <article-title>Mechanisms of vasovagal syncope in the young: reduced systemic vascular resistance versus reduced cardiac output</article-title>. <source>J Am Heart Assoc</source>. (<year>2017</year>) <volume>6</volume>:<fpage>e004417</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.116.004417</pub-id><pub-id pub-id-type="pmid">28100453</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brindley</surname><given-names>RL</given-names></name><name><surname>Bauer</surname><given-names>MB</given-names></name><name><surname>Blakely</surname><given-names>RD</given-names></name><name><surname>Currie</surname><given-names>KPM</given-names></name></person-group>. <article-title>Serotonin and serotonin transporters in the adrenal medulla: a potential hub for modulation of the sympathetic stress response</article-title>. <source>ACS Chem Neurosci</source>. (<year>2017</year>) <volume>8</volume>:<fpage>943</fpage>&#x2013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1021/acschemneuro.7b00026</pub-id><pub-id pub-id-type="pmid">28406285</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>JM</given-names></name></person-group>. <article-title>A new guideline for diagnosis and treatment of syncope in children and adolescents that stimulates further thought and discussion</article-title>. <source>Sci Bull (Beijing)</source>. (<year>2018</year>) <volume>63</volume>:<fpage>1527</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.scib.2018.09.020</pub-id><pub-id pub-id-type="pmid">30820363</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brignole</surname><given-names>M</given-names></name><name><surname>Moya</surname><given-names>A</given-names></name><name><surname>de Lange</surname><given-names>FJ</given-names></name><name><surname>Deharo</surname><given-names>JC</given-names></name><name><surname>Elliott</surname><given-names>PM</given-names></name><name><surname>Fanciulli</surname><given-names>A</given-names></name><etal/></person-group> <article-title>2018 ESC guidelines for the diagnosis and management of syncope</article-title>. <source>Kardiol Pol</source>. (<year>2018</year>) <volume>76</volume>:<fpage>1119</fpage>&#x2013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.5603/KP.2018.0161</pub-id><pub-id pub-id-type="pmid">30117520</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheldon</surname><given-names>RS</given-names></name><name><surname>Grubb</surname><given-names>BP</given-names><suffix>2nd</suffix></name><name><surname>Olshansky</surname><given-names>B</given-names></name><name><surname>Shen</surname><given-names>WK</given-names></name><name><surname>Calkins</surname><given-names>H</given-names></name><name><surname>Brignole</surname><given-names>M</given-names></name><etal/></person-group> <article-title>2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope</article-title>. <source>Heart Rhythm</source>. (<year>2015</year>) <volume>12</volume>:<fpage>e41</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2015.03.029</pub-id><pub-id pub-id-type="pmid">25980576</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Benditt</surname><given-names>DG</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name></person-group>. <article-title>Vasovagal syncope or psychogenic pseudosyncope: a major issue in the differential diagnosis of apparent transient loss of consciousness in children</article-title>. <source>Sci Bull (Beijing)</source>. (<year>2022</year>) <volume>67</volume>:<fpage>1618</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.scib.2022.07.024</pub-id><pub-id pub-id-type="pmid">36546036</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>REY</given-names></name><name><surname>Khan</surname><given-names>FM</given-names></name><name><surname>Hockin</surname><given-names>BCD</given-names></name><name><surname>Lobban</surname><given-names>TCA</given-names></name><name><surname>Sanatani</surname><given-names>S</given-names></name><name><surname>Claydon</surname><given-names>VE</given-names></name></person-group>. <article-title>Faintly tired: a systematic review of fatigue in patients with orthostatic syncope</article-title>. <source>Clin Auton Res</source>. (<year>2022</year>) <volume>32</volume>:<fpage>185</fpage>&#x2013;<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1007/s10286-022-00868-z</pub-id><pub-id pub-id-type="pmid">35689118</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strickberger</surname><given-names>SA</given-names></name><name><surname>Benson</surname><given-names>DW</given-names></name><name><surname>Biaggioni</surname><given-names>I</given-names></name><name><surname>Callans</surname><given-names>DJ</given-names></name><name><surname>Cohen</surname><given-names>MI</given-names></name><name><surname>Ellenbogen</surname><given-names>KA</given-names></name><etal/></person-group> <article-title>AHA/ACCF scientific statement on the evaluation of syncope: from the American Heart Association councils on clinical cardiology, cardiovascular nursing, cardiovascular disease in the young, and stroke, and the quality of care and outcomes research interdisciplinary working group; and the American College of Cardiology foundation: in collaboration with the heart rhythm society: endorsed by the American autonomic society</article-title>. <source>Circulation</source>. (<year>2006</year>) <volume>113</volume>:<fpage>316</fpage>&#x2013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.170274</pub-id><pub-id pub-id-type="pmid">16418451</pub-id></citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Macedo</surname><given-names>P</given-names></name><name><surname>Leite</surname><given-names>LR</given-names></name><name><surname>Asirvatham</surname><given-names>SJ</given-names></name><name><surname>Hachul</surname><given-names>DT</given-names></name><name><surname>Dos Santos-Neto</surname><given-names>LL</given-names></name><name><surname>Shen</surname><given-names>W-K</given-names></name></person-group>. <article-title>Head up tilt testing: an appraisal of its current role in the management of patients with syncope</article-title>. <source>J Atr Fibrillation</source>. (<year>2011</year>) <volume>4</volume>:<fpage>333</fpage>. <pub-id pub-id-type="doi">10.4022/jafib.333</pub-id><pub-id pub-id-type="pmid">28496692</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Teodorovich</surname><given-names>N</given-names></name><name><surname>Swissa</surname><given-names>M</given-names></name></person-group>. <article-title>Tilt table test today - state of the art</article-title>. <source>World J Cardiol</source>. (<year>2016</year>) <volume>8</volume>:<fpage>277</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.4330/wjc.v8.i3.277</pub-id><pub-id pub-id-type="pmid">27022459</pub-id></citation></ref>
<ref id="B33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>MP</given-names></name><name><surname>Duncan</surname><given-names>GW</given-names></name><name><surname>Parry</surname><given-names>SW</given-names></name></person-group>. <article-title>Head-up tilt table testing: a state-of-the-art review</article-title>. <source>Minerva Med</source>. (<year>2009</year>) <volume>100</volume>:<fpage>329</fpage>&#x2013;<lpage>38</lpage>.<pub-id pub-id-type="pmid">19749686</pub-id></citation></ref>
<ref id="B34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Placidi</surname><given-names>S</given-names></name><name><surname>Drago</surname><given-names>F</given-names></name><name><surname>Milioni</surname><given-names>M</given-names></name><name><surname>Verticelli</surname><given-names>L</given-names></name><name><surname>Tamburri</surname><given-names>I</given-names></name><name><surname>Silvetti</surname><given-names>MS</given-names></name><etal/></person-group> <article-title>Miniaturized implantable loop recorder in small patients: an effective approach to the evaluation of subjects at risk of sudden death</article-title>. <source>Pacing Clin Electrophysiol</source>. (<year>2016</year>) <volume>39</volume>:<fpage>669</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1111/pace.12866</pub-id><pub-id pub-id-type="pmid">27062386</pub-id></citation></ref>
<ref id="B35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bogossian</surname><given-names>H</given-names></name><name><surname>Alhanafi</surname><given-names>D</given-names></name><name><surname>Kloppe</surname><given-names>A</given-names></name><name><surname>H&#x00F6;ltgen</surname><given-names>R</given-names></name><name><surname>Mijic</surname><given-names>D</given-names></name></person-group>. <article-title>Stress testing: a relevant examination in rhythmology</article-title>. <source>Herzschrittmacherther Elektrophysiol</source>. (<year>2023</year>) <volume>34</volume>:<fpage>333</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s00399-023-00967-y</pub-id><pub-id pub-id-type="pmid">37874381</pub-id></citation></ref>
<ref id="B36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haberman</surname><given-names>ZC</given-names></name><name><surname>Jahn</surname><given-names>RT</given-names></name><name><surname>Bose</surname><given-names>R</given-names></name><name><surname>Tun</surname><given-names>H</given-names></name><name><surname>Shinbane</surname><given-names>JS</given-names></name><name><surname>Doshi</surname><given-names>RN</given-names></name><etal/></person-group> <article-title>Wireless smartphone ECG enables large-scale screening in diverse populations</article-title>. <source>J Cardiovasc Electrophysiol</source>. (<year>2015</year>) <volume>26</volume>:<fpage>520</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1111/jce.12634</pub-id><pub-id pub-id-type="pmid">25651872</pub-id></citation></ref>
<ref id="B37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Longo</surname><given-names>S</given-names></name><name><surname>Legramante</surname><given-names>JM</given-names></name><name><surname>Rizza</surname><given-names>S</given-names></name><name><surname>Federici</surname><given-names>M</given-names></name></person-group>. <article-title>Vasovagal syncope: an overview of pathophysiological mechanisms</article-title>. <source>Eur J Intern Med</source>. (<year>2023</year>) <volume>112</volume>:<fpage>6</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejim.2023.03.025</pub-id><pub-id pub-id-type="pmid">37030995</pub-id></citation></ref>
<ref id="B38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Villafane</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>JR</given-names></name><name><surname>Glickstein</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>JN</given-names></name><name><surname>Wagner</surname><given-names>J</given-names></name><name><surname>Snyder</surname><given-names>CS</given-names></name><etal/></person-group> <article-title>Loss of consciousness in the young child</article-title>. <source>Pediatr Cardiol</source>. (<year>2021</year>) <volume>42</volume>:<fpage>234</fpage>&#x2013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1007/s00246-020-02498-6</pub-id><pub-id pub-id-type="pmid">33388850</pub-id></citation></ref>
<ref id="B39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donmez</surname><given-names>YN</given-names></name><name><surname>Giray</surname><given-names>D</given-names></name><name><surname>Epcacan</surname><given-names>S</given-names></name><name><surname>Yalcin</surname><given-names>SS</given-names></name></person-group>. <article-title>Comorbidity of behavioral problems and parental acceptance-rejection in children diagnosed with chest discomfort, palpitations, vasovagal syncope, and underlying heart disease: a multiple case-control study</article-title>. <source>BMC Psychiatry</source>. (<year>2024</year>) <volume>24</volume>:<fpage>70</fpage>. <pub-id pub-id-type="doi">10.1186/s12888-024-05527-3</pub-id><pub-id pub-id-type="pmid">38267932</pub-id></citation></ref>
<ref id="B40"><label>40.</label><citation citation-type="journal"><comment>Task Force for the Diagnosis and Management of Syncope; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA); Heart Failure Association (HFA); Heart Rhythm Society (HRS); Moya A, et al.</comment> <article-title>Guidelines for the diagnosis and management of syncope (version 2009)</article-title>. <source>Eur Heart J</source>. (<year>2009</year>) <volume>30</volume>:<fpage>2631</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehp298</pub-id><pub-id pub-id-type="pmid">19713422</pub-id></citation></ref>
<ref id="B41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raj</surname><given-names>V</given-names></name><name><surname>Rowe</surname><given-names>AA</given-names></name><name><surname>Fleisch</surname><given-names>SB</given-names></name><name><surname>Paranjape</surname><given-names>SY</given-names></name><name><surname>Arain</surname><given-names>AM</given-names></name><name><surname>Nicolson</surname><given-names>SE</given-names></name></person-group>. <article-title>Psychogenic pseudosyncope: diagnosis and management</article-title>. <source>Auton Neurosci</source>. (<year>2014</year>) <volume>184</volume>:<fpage>66</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.autneu.2014.05.003</pub-id><pub-id pub-id-type="pmid">24882462</pub-id></citation></ref>
<ref id="B42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>M</given-names></name><name><surname>Pachon Maetos</surname><given-names>JC</given-names></name><name><surname>Kichloo</surname><given-names>A</given-names></name><name><surname>Masudi</surname><given-names>S</given-names></name><name><surname>Grubb</surname><given-names>BP</given-names></name><name><surname>Kanjwal</surname><given-names>K</given-names></name></person-group>. <article-title>Management strategies for vasovagal syncope</article-title>. <source>Pacing Clin Electrophysiol</source>. (<year>2021</year>) <volume>44</volume>:<fpage>2100</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/pace.14402</pub-id><pub-id pub-id-type="pmid">34748224</pub-id></citation></ref>
<ref id="B43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Dijk</surname><given-names>JG</given-names></name><name><surname>Sheldon</surname><given-names>R</given-names></name><name><surname>Sutton</surname><given-names>R</given-names></name></person-group>. <article-title>Making certain that noninvasive therapy for vasovagal syncope has failed before proceeding to invasive interventions</article-title>. <source>Europace</source>. (<year>2024</year>) <volume>26</volume>:<fpage>euae081</fpage>. <pub-id pub-id-type="doi">10.1093/europace/euae081</pub-id><pub-id pub-id-type="pmid">38619827</pub-id></citation></ref>
<ref id="B44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alharbi</surname><given-names>A</given-names></name><name><surname>Shah</surname><given-names>M</given-names></name><name><surname>Gupta</surname><given-names>M</given-names></name><name><surname>Rejent</surname><given-names>K</given-names></name><name><surname>Mahmoud</surname><given-names>M</given-names></name><name><surname>Alsughayer</surname><given-names>A</given-names></name><etal/></person-group> <article-title>The efficacy of non-pharmacological and non-pacing therapies in preventing vasovagal syncope: tilt training, physical counter pressure maneuvers, and yoga - a systematic review and meta-analysis</article-title>. <source>Auton Neurosci</source>. (<year>2024</year>) <volume>251</volume>:<fpage>103144</fpage>. <pub-id pub-id-type="doi">10.1016/j.autneu.2023.103144</pub-id><pub-id pub-id-type="pmid">38181551</pub-id></citation></ref>
<ref id="B45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Dijk</surname><given-names>N</given-names></name><name><surname>Quartieri</surname><given-names>F</given-names></name><name><surname>Blanc</surname><given-names>JJ</given-names></name><name><surname>Garcia-Civera</surname><given-names>R</given-names></name><name><surname>Brignole</surname><given-names>M</given-names></name><name><surname>Moya</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the physical counterpressure manoeuvres trial (PC-trial)</article-title>. <source>J Am Coll Cardiol</source>. (<year>2006</year>) <volume>48</volume>:<fpage>1652</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2006.06.059</pub-id><pub-id pub-id-type="pmid">17045903</pub-id></citation></ref>
<ref id="B46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>G</given-names></name><name><surname>Ramakumar</surname><given-names>V</given-names></name><name><surname>Sharique</surname><given-names>M</given-names></name><name><surname>Bhatia</surname><given-names>R</given-names></name><name><surname>Naik</surname><given-names>N</given-names></name><name><surname>Mohanty</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Effect of yoga on clinical outcomes and quality of life in patients with vasovagal syncope (LIVE-yoga)</article-title>. <source>JACC Clinical Electrophysiology</source>. (<year>2022</year>) <volume>8</volume>:<fpage>141</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacep.2021.09.007</pub-id><pub-id pub-id-type="pmid">35210069</pub-id></citation></ref>
<ref id="B47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ballantyne</surname><given-names>BA</given-names></name><name><surname>Letourneau-Shesaf</surname><given-names>S</given-names></name><name><surname>Raj</surname><given-names>SR</given-names></name></person-group>. <article-title>Management of vasovagal syncope</article-title>. <source>Auton Neurosci</source>. (<year>2021</year>) <volume>236</volume>:<fpage>102904</fpage>. <pub-id pub-id-type="doi">10.1016/j.autneu.2021.102904</pub-id><pub-id pub-id-type="pmid">34763249</pub-id></citation></ref>
<ref id="B48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salim</surname><given-names>MA</given-names></name><name><surname>Di Sessa</surname><given-names>TG</given-names></name></person-group>. <article-title>Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial</article-title>. <source>J Am Coll Cardiol</source>. (<year>2005</year>) <volume>45</volume>:<fpage>484</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2004.11.033</pub-id><pub-id pub-id-type="pmid">15708690</pub-id></citation></ref>
<ref id="B49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X-Y</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>L-J</given-names></name><name><surname>Hu</surname><given-names>C-Y</given-names></name><name><surname>Lin</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>M-X</given-names></name><etal/></person-group> <article-title>Efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope</article-title>. <source>Zhonghua Yi Xue Za Zhi</source>. (<year>2009</year>) <volume>89</volume>:<fpage>1951</fpage>&#x2013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">19950567</pub-id></citation></ref>
<ref id="B50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>C</given-names></name><name><surname>Du</surname><given-names>J</given-names></name></person-group>. <article-title>Randomized comparison of metoprolol versus conventional treatment in preventing recurrence of vasovagal syncope in children and adolescents</article-title>. <source>Med Sci Monit</source>. (<year>2008</year>) <volume>14</volume>:<fpage>CR199</fpage>&#x2013;<lpage>203</lpage>.<pub-id pub-id-type="pmid">18376348</pub-id></citation></ref>
<ref id="B51"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flevari</surname><given-names>P</given-names></name><name><surname>Leftheriotis</surname><given-names>D</given-names></name><name><surname>Repasos</surname><given-names>E</given-names></name><name><surname>Katsaras</surname><given-names>D</given-names></name><name><surname>Katsimardos</surname><given-names>A</given-names></name><name><surname>Lekakis</surname><given-names>J</given-names></name></person-group>. <article-title>Fluoxetine vs. placebo for the treatment of recurrent vasovagal syncope with anxiety sensitivity</article-title>. <source>Europace</source>. (<year>2017</year>) <volume>19</volume>:<fpage>127</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1093/europace/euw153</pub-id><pub-id pub-id-type="pmid">27702846</pub-id></citation></ref>
<ref id="B52"><label>52.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brignole</surname><given-names>M</given-names></name><name><surname>Menozzi</surname><given-names>C</given-names></name><name><surname>Moya</surname><given-names>A</given-names></name><name><surname>Andresen</surname><given-names>D</given-names></name><name><surname>Blanc</surname><given-names>JJ</given-names></name><name><surname>Krahn</surname><given-names>AD</given-names></name><etal/></person-group> <article-title>Pacemaker therapy in patients with neurally mediated syncope and documented asystole: third international study on syncope of uncertain etiology (ISSUE-3): a randomized trial</article-title>. <source>Circulation</source>. (<year>2012</year>) <volume>125</volume>:<fpage>2566</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.082313</pub-id><pub-id pub-id-type="pmid">22565936</pub-id></citation></ref>
<ref id="B53"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>R</given-names></name><name><surname>de Jong</surname><given-names>JSY</given-names></name><name><surname>Stewart</surname><given-names>JM</given-names></name><name><surname>Fedorowski</surname><given-names>A</given-names></name><name><surname>de Lange</surname><given-names>FJ</given-names></name></person-group>. <article-title>Pacing in vasovagal syncope: physiology, pacemaker sensors, and recent clinical trials-precise patient selection and measurable benefit</article-title>. <source>Heart Rhythm</source>. (<year>2020</year>) <volume>17</volume>:<fpage>821</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2020.01.029</pub-id><pub-id pub-id-type="pmid">32036025</pub-id></citation></ref>
<ref id="B54"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Debruyne</surname><given-names>P</given-names></name><name><surname>Rossenbacker</surname><given-names>T</given-names></name><name><surname>Janssens</surname><given-names>L</given-names></name><name><surname>Collienne</surname><given-names>C</given-names></name><name><surname>Ector</surname><given-names>J</given-names></name><name><surname>Haemers</surname><given-names>P</given-names></name><etal/></person-group> <article-title>Durable physiological changes and decreased syncope burden 12 months after unifocal right-sided ablation under computed tomographic guidance in patients with neurally mediated syncope or functional Sinus node dysfunction</article-title>. <source>Circ Arrhythm Electrophysiol</source>. (<year>2021</year>) <volume>14</volume>:<fpage>e009747</fpage>. <pub-id pub-id-type="doi">10.1161/CIRCEP.120.009747</pub-id><pub-id pub-id-type="pmid">33999698</pub-id></citation></ref>
<ref id="B55"><label>55.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Shao</surname><given-names>W</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name></person-group>. <article-title>Efficacy of catheter ablation in ganglionated plexus for malignant vasovagal syncope children</article-title>. <source>Cardiol Young</source>. (<year>2024</year>) <volume>34</volume>:<fpage>1571</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1017/S1047951124000659</pub-id><pub-id pub-id-type="pmid">38572563</pub-id></citation></ref>
<ref id="B56"><label>56.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>PML</given-names></name><name><surname>Silva</surname><given-names>RMFL</given-names></name><name><surname>Tonelli</surname><given-names>HAF</given-names></name><name><surname>Meira</surname><given-names>ZMA</given-names></name><name><surname>Mota</surname><given-names>CCC</given-names></name></person-group>. <article-title>Clinical and autonomic profile, and modified calgary score for children and adolescents with presumed vasovagal syncope submitted to the tilt test</article-title>. <source>Arq Bras Cardiol</source>. (<year>2023</year>) <volume>120</volume>:<fpage>e20220543</fpage>. <pub-id pub-id-type="doi">10.36660/abc.20220543</pub-id><pub-id pub-id-type="pmid">37556654</pub-id></citation></ref>
<ref id="B57"><label>57.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kara</surname><given-names>A</given-names></name><name><surname>Dogan</surname><given-names>MT</given-names></name></person-group>. <article-title>The psychopathology, depression, and anxiety levels of children and adolescents with vasovagal syncope: a case-control study</article-title>. <source>J Nerv Ment Dis</source>. (<year>2021</year>) <volume>209</volume>:<fpage>547</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1097/NMD.0000000000001334</pub-id><pub-id pub-id-type="pmid">33840767</pub-id></citation></ref>
<ref id="B58"><label>58.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maron</surname><given-names>BJ</given-names></name><name><surname>Zipes</surname><given-names>DP</given-names></name><name><surname>Kovacs</surname><given-names>RJ</given-names></name></person-group>. <article-title>Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology</article-title>. <source>J Am Coll Cardiol</source>. (<year>2015</year>) <volume>66</volume>:<fpage>2343</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2015.09.032</pub-id><pub-id pub-id-type="pmid">26542655</pub-id></citation></ref>
<ref id="B59"><label>59.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Towheed</surname><given-names>A</given-names></name><name><surname>Nesheiwat</surname><given-names>Z</given-names></name><name><surname>Mangi</surname><given-names>MA</given-names></name><name><surname>Karabin</surname><given-names>B</given-names></name><name><surname>Grubb</surname><given-names>BP</given-names></name></person-group>. <article-title>Ivabradine in children with postural orthostatic tachycardia syndrome: a retrospective study</article-title>. <source>Cardiol Young</source>. (<year>2020</year>) <volume>30</volume>:<fpage>975</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1017/S1047951120001341</pub-id><pub-id pub-id-type="pmid">32498748</pub-id></citation></ref>
<ref id="B60"><label>60.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coffin</surname><given-names>ST</given-names></name><name><surname>Raj</surname><given-names>SR</given-names></name></person-group>. <article-title>Non-invasive management of vasovagal syncope</article-title>. <source>Auton Neurosci</source>. (<year>2014</year>) <volume>184</volume>:<fpage>27</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.autneu.2014.06.004</pub-id><pub-id pub-id-type="pmid">24996861</pub-id></citation></ref>
<ref id="B61"><label>61.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Biffi</surname><given-names>M</given-names></name><name><surname>Boriani</surname><given-names>G</given-names></name><name><surname>Bronzetti</surname><given-names>G</given-names></name><name><surname>Frabetti</surname><given-names>L</given-names></name><name><surname>Picchio</surname><given-names>FM</given-names></name><name><surname>Branzi</surname><given-names>A</given-names></name></person-group>. <article-title>Neurocardiogenic syncope in selected pediatric patients&#x2013;natural history during long-term follow-up and effect of prophylactic pharmacological therapy</article-title>. <source>Cardiovasc Drugs Ther</source>. (<year>2001</year>) <volume>15</volume>:<fpage>161</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1023/a:1011179014084</pub-id><pub-id pub-id-type="pmid">11669410</pub-id></citation></ref>
<ref id="B62"><label>62.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Kang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group>. <article-title>Development of prognostic nomogram model to predict syncope recurrence in children with vasovagal syncope</article-title>. <source>Front Cardiovasc Med</source>. (<year>2023</year>) <volume>10</volume>:<fpage>1099115</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2023.1099115</pub-id><pub-id pub-id-type="pmid">36970348</pub-id></citation></ref>
<ref id="B63"><label>63.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>JB</given-names></name><name><surname>Czosek</surname><given-names>RJ</given-names></name><name><surname>Knilans</surname><given-names>TK</given-names></name><name><surname>Marino</surname><given-names>BS</given-names></name></person-group>. <article-title>The effect of paediatric syncope on health-related quality of life</article-title>. <source>Cardiol Young</source>. (<year>2012</year>) <volume>22</volume>:<fpage>583</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1017/S1047951112000133</pub-id><pub-id pub-id-type="pmid">22348920</pub-id></citation></ref>
<ref id="B64"><label>64.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Tian</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Dong</surname><given-names>X-Y</given-names></name><etal/></person-group> <article-title>Guidelines for the diagnosis and treatment of neurally mediated syncope in children and adolescents (revised 2024)</article-title>. <source>World J Pediatrics</source>. (<year>2024</year>) <volume>20</volume>:<fpage>983</fpage>&#x2013;<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1007/s12519-024-00819-w</pub-id></citation></ref>
<ref id="B65"><label>65.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soteriades</surname><given-names>ES</given-names></name><name><surname>Evans</surname><given-names>JC</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>Chen</surname><given-names>MH</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><etal/></person-group> <article-title>Incidence and prognosis of syncope</article-title>. <source>N Engl J Med</source>. (<year>2002</year>) <volume>347</volume>:<fpage>878</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa012407</pub-id><pub-id pub-id-type="pmid">12239256</pub-id></citation></ref>
<ref id="B66"><label>66.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bar&#x00F3;n-Esquivias</surname><given-names>G</given-names></name><name><surname>Err&#x00E1;zquin</surname><given-names>F</given-names></name><name><surname>Pedrote</surname><given-names>A</given-names></name><name><surname>Cayuela</surname><given-names>A</given-names></name><name><surname>G&#x00F3;mez</surname><given-names>S</given-names></name><name><surname>Aguilera</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Long-term outcome of patients with vasovagal syncope</article-title>. <source>Am Heart J</source>. (<year>2004</year>) <volume>147</volume>:<fpage>883</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.ahj.2003.11.022</pub-id></citation></ref>
<ref id="B67"><label>67.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gielerak</surname><given-names>G</given-names></name><name><surname>Szyfner</surname><given-names>K</given-names></name></person-group>. <article-title>Physical training improves orthostatic tolerance. Patterns of physical activity that are useful in prevention of vasovagal syncope</article-title>. <source>Kardiol Pol</source>. (<year>2006</year>) <volume>64</volume>:<fpage>316</fpage>&#x2013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">16583339</pub-id></citation></ref>
<ref id="B68"><label>68.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Zou</surname><given-names>R</given-names></name><name><surname>Liao</surname><given-names>D</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><etal/></person-group> <article-title>Relationship between hemodynamic type and syncopal symptoms in pediatric vasovagal syncope</article-title>. <source>Eur J Pediatr</source>. (<year>2024</year>) <volume>183</volume>:<fpage>179</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1007/s00431-023-05278-5</pub-id><pub-id pub-id-type="pmid">37855929</pub-id></citation></ref></ref-list>
</back>
</article>